🟢 Amneal Pharmaceuticals is trading 4.23% up on October 15, 2026, amid healthcare sector strength

Amneal Pharmaceuticals is trading at $19.70, up 4.23%, amid strength in healthcare shares.

• Healthcare ETF XLV is up 2.12%, supported by strong earnings from large healthcare companies.
• No verified company-specific catalyst for October 15 surfaced in searches. Amneal’s investor-relations page lists an October 14 close of $18.90; the move is best explained by sector context.